2025-01-01 2025-07-31 false Capium Accounts Production 1.1 12959904 2025-01-01 2025-07-31 12959904 bus:FullAccounts 2025-01-01 2025-07-31 12959904 bus:FRS102 2025-01-01 2025-07-31 12959904 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-07-31 12959904 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-07-31 12959904 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-07-31 12959904 2025-01-01 2025-07-31 12959904 2025-07-31 12959904 bus:RegisteredOffice 2025-01-01 2025-07-31 12959904 core:WithinOneYear 2025-07-31 12959904 core:AfterOneYear 2025-07-31 12959904 1 2025-01-01 2025-07-31 12959904 bus:Director1 2025-01-01 2025-07-31 12959904 bus:Director1 2025-07-31 12959904 bus:Director1 2024-01-01 2024-12-31 12959904 2024-01-01 12959904 bus:LeadAgentIfApplicable 2025-01-01 2025-07-31 12959904 2024-01-01 2024-12-31 12959904 2024-12-31 12959904 core:WithinOneYear 2024-12-31 12959904 core:AfterOneYear 2024-12-31 12959904 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 12959904 bus:OrdinaryShareClass1 2025-01-01 2025-07-31 12959904 bus:OrdinaryShareClass1 2025-07-31 12959904 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 12959904 bus:OrdinaryShareClass1 2024-12-31 12959904 core:ComputerEquipment 2025-01-01 2025-07-31 12959904 core:ComputerEquipment 2025-07-31 12959904 core:ComputerEquipment 2024-12-31 12959904 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-07-31 12959904 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 12959904 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 12959904 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 12959904 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-07-31 12959904 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12959904 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-07-31 12959904 core:Non-currentFinancialInstruments 2025-07-31 12959904 core:Non-currentFinancialInstruments 2024-12-31 12959904 core:ShareCapital 2025-07-31 12959904 core:ShareCapital 2024-12-31 12959904 core:RetainedEarningsAccumulatedLosses 2025-07-31 12959904 core:RetainedEarningsAccumulatedLosses 2024-12-31 12959904 core:ShareCapitalOrdinaryShares 2025-01-01 12959904 core:ShareCapitalOrdinaryShares 2024-01-01 12959904 core:ShareCapitalOrdinaryShares 2025-01-01 2025-07-31 12959904 core:ShareCapitalOrdinaryShares 2024-01-01 2024-12-31 12959904 core:ShareCapitalOrdinaryShares 2025-07-31 12959904 core:ShareCapitalOrdinaryShares 2024-12-31 12959904 core:RetainedEarningsAccumulatedLosses 2025-01-01 12959904 core:RetainedEarningsAccumulatedLosses 2024-01-01 12959904 core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-07-31 12959904 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 12959904 core:RetainedEarningsAccumulatedLosses 2025-07-31 12959904 core:RetainedEarningsAccumulatedLosses 2024-12-31 12959904 dpl:Item1 2025-01-01 12959904 dpl:Item1 2025-07-31 12959904 dpl:Item1 2024-01-01 12959904 dpl:Item1 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12959904
England and Wales

 

 

 

RIVERPHARMA LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2025

End date: 31 July 2025
Director SECIL GEYIK
Registered Number 12959904
Registered Office 15 HORNBEAM CLOSE
OADBY
LEICESTER
ENGLAND
LE2 4EQ
Accountants SMART ACCOUNTING AND CONSULTANCY LTD
RUTLAND HOUSE
23-25 FRIAR LANE
LEICESTER
LE1 5QQ
1
Director's report and financial statements
The director presents her annual report and the financial statements for the year ended 31 July 2025.
Principal activities
Principal activity of the company during the financial period was Other professional, scientific, and technical activities not elsewhere classified.
Director
The director who served the company throughout the period was as follows:
Shares
SECIL GEYIK 1000.00
Statement of director's responsibilities
The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.

In preparing these financial statements, the director is required to :
  • select suitable accounting policies and then apply them consistently
  • make judgements and accounting estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions

On behalf of the board.


----------------------------------
SECIL GEYIK
Director

Date approved: 17 August 2025
2
Accountant’s report
You consider that the company is exempt from an audit for the year ended 31 July 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
SMART ACCOUNTING AND CONSULTANCY LTD
31 July 2025



....................................................

SMART ACCOUNTING AND CONSULTANCY LTD

RUTLAND HOUSE
23-25 FRIAR LANE
LEICESTER
LE1 5QQ
17 August 2025
3
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 1,511    72 
1,511    72 
Current assets      
Debtors 4 13,588    7,714 
Cash at bank and in hand 7,667    17,582 
21,255    25,296 
Creditors: amount falling due within one year 5 (10,526)   (5,130)
Net current assets 10,729    20,166 
 
Total assets less current liabilities 12,240    20,238 
Net assets 12,240    20,238 
 

Capital and reserves
     
Called up share capital 6 1,000    1,000 
Profit and loss account 11,240    19,238 
Shareholders' funds 12,240    20,238 
 


For the period ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 17 August 2025 and were signed by:


-------------------------------
SECIL GEYIK
Director
4
  Equity share capital   Retained Earnings   Total
£ £ £
At 01 January 2024 1,000  8,476  9,476 
Profit for the period 15,612  15,612 
Total comprehensive income for the period 15,612  15,612 
Dividends (4,850) (4,850)
Total investments by and distributions to owners (4,850) (4,850)
At 31 December 2024 1,000  19,238  20,238 
At 01 January 2025 1,000  19,238  20,238 
Profit for the period 9,452  9,452 
Total comprehensive income for the period 9,452  9,452 
Dividends (17,450) (17,450)
Total investments by and distributions to owners (17,450) (17,450)
At 31 July 2025 1,000  11,240  12,240 
5
General Information
RIVERPHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 12959904, registration address 15 HORNBEAM CLOSE, OADBY , LEICESTER, ENGLAND, LE2 4EQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Preference dividends
Where preference shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 20% Straight Line
2.

Average number of employees

Average number of employees during the period was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 January 2025 480    480 
Additions 1,614    1,614 
Disposals  
At 31 July 2025 2,094    2,094 
Depreciation
At 01 January 2025 408    408 
Charge for period 175    175 
On disposals  
At 31 July 2025 583    583 
Net book values
Closing balance as at 31 July 2025 1,511    1,511 
Opening balance as at 01 January 2025 72    72 


4.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 13,588    7,714 
13,588    7,714 

5.

Creditors: amount falling due within one year

2025
£
  2024
£
Trade Creditors 321    500 
Corporation Tax 5,558    3,679 
PAYE & Social Security 590    293 
Other Creditors 9    10 
Directors' Current Accounts 4,048    648 
10,526    5,130 

6.

Share Capital

Authorised
1,000 Class A shares of £1.00 each
Allotted, called up and fully paid
2025
£
  2024
£
1,000 Class A shares of £1.00 each 1,000    1,000 
1,000    1,000 

6